Autonomicfunctions were studied in 10 respiratory-support patients with motor neuron disease (MND)at its most advanced stage by means of hemodynamicfunction tests. The mean duration of disease was 83.4 months (SD 28.0, range 50-140 months). All the patients in this study had lost their ability to breathe spontaneously and were ventilated by respirator. Hemodynamic function tests were performed in 8 out of 10 patients. These patients showed exaggerated sympathetic vasomotor reflexes, increased reflex hypertension and tachycardia in response to the cold pressor test and increased response to administration of adrenaline. However, the responses to both the Aschner eyeball pressure test and injection ofatropine were normal, indicating normal parasympathetic nervous system function. Plasma and urine levels of norepinephrine, epinephrine and their metabolites were almost normal in all 10 patients, as were serum dopamine-B-hydroxylase levels. In patients with the most advanced stage of MND, hyperfunction of the adrenergic sympatheticnervoussystemwasobserved, and this wasconsidered to be a symptom characteristic ofMND. (Internal Medicine 34: 972-975, 1995) 
Introduction
The prominent clinical features of motor neuron disease (MND)are signs of lesions in the upper and lower motor neurons such as increased tendon reflexes or spasticity and muscle wasting. Most clinical observations have failed to demonstrate signs of autonomic failure, and the consensus remains that functions mediated by the autonomic nervous system are generally intact (1) (2) (3) .
Recently, however, neuroanatomical studies have cast somedoubt as to whether the autonomic nervous system is truly spared in MND (4) . Neurophysiological studies, including sympathetic skin response (5, 6) and hemodynamic function tests (7-9), have also suggested the possibility of alterations in the function of the autonomic nervous system in MND. It has been reported that the severity of sympathetic nervous system function is statistically more likely to diminish in the advanced stage of the disease (9).
Earlier clinical studies in MNDpatients were discontinued at the time of death resulting from respiratory failure. However, with recent advances in the use of life-support apparatus, MND patients live beyond the point of respiratory failure. In the present study, we examined the functions of the autonomic nervous system in respiratory-support patients with the most advanced-stage of MND, who show total paralysis of the voluntary muscles, sometimes including the ocular muscles.
Patients and Methods
Studies were conducted in seven MNDpatients with pyramidal signs, in other words amyotrophic lateral sclerosis (ALS) (5 males, 2 females; mean age 63.1, SD 5.1 years; range 52-68 years) and three patients with MNDwithout pyramidal signs, which was classified as spinal progressive muscle atrophy (SPMA) (2 males, one female; mean age 63.7, SD 5.6, range 56-69 years). The diagnosis was based upon clinical features and the results of thorough neurophysiological evaluations. These patients had lost their ability to movevoluntarily, and in some patients the paralysis of extraocular movements was observed. They were ventilated by respirators, and were duration of the disease before they required respirators and became bed-ridden was 42.9 months (SD 27.2, range 5-86 months) in the ALS patients and 58.2 months (SD 26.8, range 10-97 months) in those with SPMA.None of the patients had a family history of the disease and no dementia was observed. Informed consent was obtained, and the experiments were approved by the local ethics committee. Cardiovascular responses to adrenaline (adrenaline hydrochloride, 1 3 jixg/kg, s.c.) and atropine (atropine surfoxide, 1 3 jag/ kg, s.c.) were studied in 5 patients with ALS and in 3 with SPMA(6 males and 2 females; mean age 62.5, SD 5.5, range 52-69 years). The mean duration of MNDin these 8 patients was 75.9 months (SD 22.8, range 50-126 months). The mean time for which they had required respirators was 36.0 months (SD 25.9, range 5-86 months) and the time since they had lost their ability to stand was 51.3 months (SD 25.1, range 10-97 months). Changes in heart rate and blood pressure were automatically monitored up to one hour after the injections and other clinical symptoms were observed. The response to adrenaline was evaluated according to the modification of Polinsky's criteria (10, ll): (i) 30 beats/min or more increase in heart rate, (ii) 30 mmHgor greater increase in bloodpressure, (iii) the appearance of symptoms such as palpitation, anxiety, or hyperventilation. If three of these criteria were observed, the response was evaluated as +++. If two or one were observed, it was calssed as ++ or +, respectively. After the injection of atropine, the response was categorized as adrenaline (1 1): (i) 30 beats/ min or greater increase in heart rate, (ii) dry mouth, (iii) the appearance of symptoms such as headache, palpitation, or mydriasis. Reflex hypertension and tachycardia in response to the cold pressor test, and reflex bradycardia and hypotension to the Aschner eyeball pressure test were comparedwith the agematched means reported by Tamura et al (8) .
Plasma and urine levels of norepinephrine, epinephrine, dopamine, vanillyl mandelic acid (VMA), homovanillic acid (HVA), cortisol, 5-hydroxyindole acetic acid (5-HIAA) were measured in 10 patients, and serum dopamine-p-hydroxylase (DBH) activity was measured in 8. These were selected as quantitative tests of sympathetic function. Blood was collected in the resting state, between 07.00 and 09.00h, and 24-hour urine collection was made. DBHwas measured by the photometric assay of Nagatsu and Udenfreid (12) . Other substances were measured by high-performance liquid chromatography.
Results
There was no autonomic dysfunction in the patients with MNDon routine physical examination, except in two patients with SPMAand one with ALSwho showed excessive sweating.
Hemodynamicfunction tests revealed that there was hyperfunction of the sympathetic nervous system in these patients with advanced-stage MND,while the functioning of the parasympathetic nervous system remained almost normal. The response to the adrenaline injection was abnormally higher Table 2 ). The epinephrine level also remained normal (normal range <100 pg/ml). Dopamine, HVA, VMA and 5-HIAA concentrations were normal in plasma or urine, as well as epinephrine and norepinephrine. The level of VMAin urine was within the normal limit. The DBHlevel was normal except in one patient with ALS. The mean serum level of DBHwas 36.7 IU// (SD 17.7, range 6.9-72.6, normal level 2-60 IU//).
Discussion
Hyperfunctionof the sympathetic nervoussystemwasobserved even in the advanced stage of MND, as revealed by excessive reactivity both to adrenaline and to the cold pressor test.
Plasma norepinephrine and epinephrine levels depend mainly on the rate of secretion from the peripheral sympathetic nerve terminals and the adrenal medulla respectively, and are therefore considered as indicators of sympathetic function (13).
DBHactivity reflects the amount of the biosynthetic enzyme that produces norepinephrine and thus is also regarded as an indicator of sympathetic activity. Increased plasma norepinephrine levels have previously been reported in patients with MND, and this increase has been statistically shown to progress during the course of disease but to diminish in the advanced stage (9). Here, we examined respiratory-support patients with the most advanced stage of MND. This condition is referred to as the totally locked-in state and represents the entire complex of clinical manifestations of MND ( 14). In the present patients, we found normal plasma and urine levels of norepinephrine, epinephrine and their metabolites, and a normal serum level of DBH.
In these patients, in spite of the normal norepinephrine levels, the reactivity to adrenaline and the cold pressor test was high. These results suggest that the sensitivity of adrenaline receptors in the arteries was increased. Because the normal plasma epinephrine level suggests normal function of the adrenal medulla, sympathetic nervous system hyperfunction observed in the present patients might not be induced by stress reactions. (16) provide evidence supporting the suggestion that MND, especially that with pyramidal signs, is a more complex disorder than is generally recognized, extending beyond the corticospinal tracts and lower motor neurons. The present study of the autonomic system in MNDsupports this idea and suggests that MNDwithout pyramidal signs (SPMA) also involves a more complex disorder.
